Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Cellectis and Kyoto University join forces for stem cell research

Oct. 26, 2010

NeuroVive and to-BBB to codevelop therapies for stroke and other CNS disorders

Oct. 26, 2010

Biogen Idec and Genentech amend collaboration agreement on CD20-targeting antibodies

Oct. 25, 2010

Depomed delivers prototype formulation of fixed-dose metformin/canagliflozin

Oct. 25, 2010

Photocure enters into agreement with Salix Pharma for photodynamic colorectal diagnostic

Oct. 22, 2010

Labopharm and Paladin Labs enter agreements on pain medications

Oct. 19, 2010

Omeros receives additional grant from NIDA for addiction program

Oct. 18, 2010

PAION and Lundbeck expand desmoteplase license agreement

Oct. 18, 2010

Medicago and PATH collaborate on broad-coverage flu vaccines

Oct. 18, 2010

BioLineRx acquires rights to Santhera's melanocortin MC4 receptor antagonists for cachexia

Oct. 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.